{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:32:38Z","timestamp":1793046758639,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Airway epithelial barrier function is maintained by the formation of tight junctions (TJs) and adherens junctions (AJs). Inhalation of cigarette smoke causes airway epithelial barrier dysfunction and may contribute to the pathogenesis of chronic lung diseases such as asthma and chronic obstructive pulmonary disease (COPD). We assessed the effects of cigarette smoke on barrier function and expression of multiple TJ and AJ proteins in the bronchial epithelium. We also examined whether treatment with glucocorticosteroids (GCSs), long-acting \u03b2<jats:sub>2<\/jats:sub>-agonists (LABAs), and human cathelicidin LL-37 can protect against cigarette smoke extract (CSE)-induced barrier dysfunction.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Calu-3 cells cultured at the air-liquid interface were pretreated with or without GCSs, LABAs, GCSs plus LABAs, or LL-37, and subsequently exposed to CSE. Barrier function was assessed by transepithelial electronic resistance (TEER) measurements. Gene and protein expression levels of TJ and AJ proteins were analyzed by quantitative PCR and western blotting, respectively. Immunofluorescence staining of TJ and AJ proteins was performed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>CSE decreased TEER and increased permeability in a concentration-dependent manner. CSE suppressed gene expression of claudin-1, claudin-3, claudin-4, claudin-7, claudin-15, occludin, E-cadherin, junctional adhesion molecule-A (JAM-A) and zonula occludens-1 (ZO-1) within 12\u2009h post-CSE exposure, while suppressed protein expression levels of occludin at 12\u2009h. CSE-treated cells exhibited discontinuous or attenuated immunostaining for claudin-1, claudin-3, claudin-4, occludin, ZO-1, and E-cadherin compared with untreated cells. GCS treatment partially restored CSE-induced TEER reduction, while LABA treatment had no effect. GCS and LABA combination treatment had no additive effect on CSE-induced TEER reduction and gene suppression of TJ and AJ proteins. Human cathelicidin LL-37 counteracted CSE-induced TEER reduction and prevented disruption of occludin and ZO-1. LL-37 also attenuated CSE-induced decreases in gene and protein expression levels of occludin.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>CSE caused airway epithelial barrier dysfunction and simultaneously downregulated multiple TJ and AJ proteins. GCS and LABA combination treatment had no additive effect on CSE-induced TEER reduction. LL-37 counteracted CSE-induced TEER reduction and prevented disruption of occludin and ZO-1. Use of LL-37 to counteract airway epithelial barrier dysfunction may have significant benefits for respiratory diseases such as asthma and COPD.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12931-019-1226-4","type":"journal-article","created":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T17:03:13Z","timestamp":1573318993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37"],"prefix":"10.1186","volume":"20","author":[{"given":"Miyoko","family":"Tatsuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7736-588X","authenticated-orcid":false,"given":"Keiko","family":"Kan-o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Fukuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitaka","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,9]]},"reference":[{"key":"1226_CR1","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(14)60446-3","volume":"385","author":"DS Postma","year":"2015","unstructured":"Postma DS, Bush A, van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet. 2015;385:899\u2013909.","journal-title":"Lancet"},{"key":"1226_CR2","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1183\/09031936.00073312","volume":"41","author":"R Polosa","year":"2013","unstructured":"Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J. 2013;41:716\u201326.","journal-title":"Eur Respir J"},{"key":"1226_CR3","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","volume":"337","author":"RA Pauwels","year":"1997","unstructured":"Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and corticosteroids establishing therapy (FACET) international study group. N Engl J Med. 1997;337:1405\u201311.","journal-title":"N Engl J Med"},{"key":"1226_CR4","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1164\/ajrccm.164.8.2104102","volume":"164","author":"PM O'Byrne","year":"2001","unstructured":"O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, Tattersfield A. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med. 2001;164:1392\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"1226_CR5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJMoa063070","volume":"356","author":"PM Calverley","year":"2007","unstructured":"Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775\u201389.","journal-title":"N Engl J Med"},{"key":"1226_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tibs.2018.09.008","volume":"44","author":"S Tsukita","year":"2019","unstructured":"Tsukita S, Tanaka H, Tamura A. The Claudins: from tight junctions to biological systems. Trends Biochem Sci. 2019;44:141\u201352.","journal-title":"Trends Biochem Sci"},{"key":"1226_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1165\/rcmb.2013-0541RT","volume":"50","author":"F Rezaee","year":"2014","unstructured":"Rezaee F, Georas SN. Breaking barriers. New insights into airway epithelial barrier function in health and disease. Am J Respir Cell Mol Biol. 2014;50:857\u201369.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1226_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jaci.2011.05.038","volume":"128","author":"C Xiao","year":"2011","unstructured":"Xiao C, Puddicombe SM, Field S, Haywood J, Broughton-Head V, Puxeddu I, Haitchi HM, Vernon-Wilson E, Sammut D, Bedke N, et al. Defective epithelial barrier function in asthma. J Allergy Clin Immunol. 2011;128:549\u201356 e541\u2013512.","journal-title":"J Allergy Clin Immunol"},{"key":"1226_CR9","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1164\/rccm.201311-1982LE","volume":"189","author":"IH Heijink","year":"2014","unstructured":"Heijink IH, Noordhoek JA, Timens W, van Oosterhout AJ, Postma DS. Abnormalities in airway epithelial junction formation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189:1439\u201342.","journal-title":"Am J Respir Crit Care Med"},{"key":"1226_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1165\/rcmb.2017-0200TR","volume":"58","author":"M Aghapour","year":"2018","unstructured":"Aghapour M, Raee P, Moghaddam SJ, Hiemstra PS, Heijink IH. Airway epithelial barrier dysfunction in chronic obstructive pulmonary disease: role of cigarette smoke exposure. Am J Respir Cell Mol Biol. 2018;58:157\u201369.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1226_CR11","doi-asserted-by":"publisher","first-page":"L581","DOI":"10.1152\/ajplung.00074.2017","volume":"313","author":"K Nishida","year":"2017","unstructured":"Nishida K, Brune KA, Putcha N, Mandke P, O'Neal WK, Shade D, Srivastava V, Wang M, Lam H, An SS, et al. Cigarette smoke disrupts monolayer integrity by altering epithelial cell-cell adhesion and cortical tension. Am J Physiol Lung Cell Mol Physiol. 2017;313:L581\u201391.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1226_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1183\/09031936.00193810","volume":"39","author":"IH Heijink","year":"2012","unstructured":"Heijink IH, Brandenburg SM, Postma DS, van Oosterhout AJ. Cigarette smoke impairs airway epithelial barrier function and cell-cell contact recovery. Eur Respir J. 2012;39:419\u201328.","journal-title":"Eur Respir J"},{"key":"1226_CR13","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1165\/rcmb.2013-0090OC","volume":"50","author":"AC Schamberger","year":"2014","unstructured":"Schamberger AC, Mise N, Jia J, Genoyer E, Yildirim AO, Meiners S, Eickelberg O. Cigarette smoke-induced disruption of bronchial epithelial tight junctions is prevented by transforming growth factor-beta. Am J Respir Cell Mol Biol. 2014;50:1040\u201352.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1226_CR14","doi-asserted-by":"publisher","first-page":"C585","DOI":"10.1152\/ajpcell.00183.2013","volume":"306","author":"A Oldenburger","year":"2014","unstructured":"Oldenburger A, Poppinga WJ, Kos F, de Bruin HG, Rijks WF, Heijink IH, Timens W, Meurs H, Maarsingh H, Schmidt M. A-kinase anchoring proteins contribute to loss of E-cadherin and bronchial epithelial barrier by cigarette smoke. Am J Physiol Cell Physiol. 2014;306:C585\u201397.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1226_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1183\/09031936.03.00098803","volume":"23","author":"R Bals","year":"2004","unstructured":"Bals R, Hiemstra PS. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J. 2004;23:327\u201333.","journal-title":"Eur Respir J"},{"key":"1226_CR16","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.pharep.2016.03.015","volume":"68","author":"A Fabisiak","year":"2016","unstructured":"Fabisiak A, Murawska N, Fichna J. LL-37: cathelicidin-related antimicrobial peptide with pleiotropic activity. Pharmacol Rep. 2016;68:802\u20138.","journal-title":"Pharmacol Rep"},{"key":"1226_CR17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1159\/000362789","volume":"6","author":"T Akiyama","year":"2014","unstructured":"Akiyama T, Niyonsaba F, Kiatsurayanon C, Nguyen TT, Ushio H, Fujimura T, Ueno T, Okumura K, Ogawa H, Ikeda S. The human cathelicidin LL-37 host defense peptide upregulates tight junction-related proteins and increases human epidermal keratinocyte barrier function. J Innate Immun. 2014;6:739\u201353.","journal-title":"J Innate Immun"},{"key":"1226_CR18","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.rmed.2012.08.018","volume":"106","author":"YY Jiang","year":"2012","unstructured":"Jiang YY, Xiao W, Zhu MX, Yang ZH, Pan XJ, Zhang Y, Sun CC, Xing Y. The effect of human antibacterial peptide LL-37 in the pathogenesis of chronic obstructive pulmonary disease. Respir Med. 2012;106:1680\u20139.","journal-title":"Respir Med"},{"key":"1226_CR19","first-page":"617","volume":"26","author":"M Golec","year":"2012","unstructured":"Golec M, Reichel C, Lemieszek M, Mackiewicz B, Buczkowski J, Sitkowska J, Skorska C, Dutkiewicz J, Milanowski J, Ziesche R. Cathelicidin LL-37 in bronchoalveolar lavage and epithelial lining fluids from COPD patients and healthy individuals. J Biol Regul Homeost Agents. 2012;26:617\u201325.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"3","key":"1226_CR20","doi-asserted-by":"publisher","first-page":"1601328","DOI":"10.1183\/13993003.01328-2016","volume":"49","author":"Louise J.P Persson","year":"2017","unstructured":"Persson LJ, Aanerud M, Hardie JA, Miodini Nilsen R, Bakke PS, Eagan TM, Hiemstra PS. Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease. Eur Respir J. 2017;49:1601328.","journal-title":"European Respiratory Journal"},{"key":"1226_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2147\/COPD.S185602","volume":"14","author":"P Uysal","year":"2019","unstructured":"Uysal P, Simsek G, Durmus S, Sozer V, Aksan H, Yurt S, Cuhadaroglu C, Kosar F, Gelisgen R, Uzun H. Evaluation of plasma antimicrobial peptide LL-37 and nuclear factor-kappaB levels in stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:321\u201330.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1226_CR22","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1378\/chest.128.4.2316","volume":"128","author":"W Xiao","year":"2005","unstructured":"Xiao W, Hsu YP, Ishizaka A, Kirikae T, Moss RB. Sputum cathelicidin, urokinase plasminogen activation system components, and cytokines discriminate cystic fibrosis, COPD, and asthma inflammation. Chest. 2005;128:2316\u201326.","journal-title":"Chest"},{"key":"1226_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejps.2014.12.017","volume":"69","author":"ME Kreft","year":"2015","unstructured":"Kreft ME, Jerman UD, Lasic E, Hevir-Kene N, Rizner TL, Peternel L, Kristan K. The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function. Eur J Pharm Sci. 2015;69:1\u20139.","journal-title":"Eur J Pharm Sci"},{"key":"1226_CR24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.intimp.2011.12.006","volume":"12","author":"A Sekiyama","year":"2012","unstructured":"Sekiyama A, Gon Y, Terakado M, Takeshita I, Kozu Y, Maruoka S, Matsumoto K, Hashimoto S. Glucocorticoids enhance airway epithelial barrier integrity. Int Immunopharmacol. 2012;12:350\u20137.","journal-title":"Int Immunopharmacol"},{"key":"1226_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12931-015-0318-z","volume":"17","author":"IH Heijink","year":"2016","unstructured":"Heijink IH, Jonker MR, de Vries M, van Oosterhout AJ, Telenga E, Ten Hacken NH, Postma DS, van den Berge M. Budesonide and fluticasone propionate differentially affect the airway epithelial barrier. Respir Res. 2016;17:2.","journal-title":"Respir Res"},{"key":"1226_CR26","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/j.1476-5381.2011.01620.x","volume":"165","author":"MM Kelly","year":"2012","unstructured":"Kelly MM, King EM, Rider CF, Gwozd C, Holden NS, Eddleston J, Zuraw B, Leigh R, O'Byrne PM, Newton R. Corticosteroid-induced gene expression in allergen-challenged asthmatic subjects taking inhaled budesonide. Br J Pharmacol. 2012;165:1737\u201347.","journal-title":"Br J Pharmacol"},{"key":"1226_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.brainres.2004.08.043","volume":"1027","author":"BT Hawkins","year":"2004","unstructured":"Hawkins BT, Abbruscato TJ, Egleton RD, Brown RC, Huber JD, Campos CR, Davis TP. Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res. 2004;1027:48\u201358.","journal-title":"Brain Res"},{"key":"1226_CR28","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1378\/chest.08-1780","volume":"135","author":"L Petecchia","year":"2009","unstructured":"Petecchia L, Sabatini F, Varesio L, Camoirano A, Usai C, Pezzolo A, Rossi GA. Bronchial airway epithelial cell damage following exposure to cigarette smoke includes disassembly of tight junction components mediated by the extracellular signal-regulated kinase 1\/2 pathway. Chest. 2009;135:1502\u201312.","journal-title":"Chest"},{"key":"1226_CR29","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1096\/fj.06-7729com","volume":"22","author":"EM Khan","year":"2008","unstructured":"Khan EM, Lanir R, Danielson AR, Goldkorn T. Epidermal growth factor receptor exposed to cigarette smoke is aberrantly activated and undergoes perinuclear trafficking. FASEB J. 2008;22:910\u20137.","journal-title":"FASEB J"},{"key":"1226_CR30","doi-asserted-by":"publisher","first-page":"L40","DOI":"10.1152\/ajplung.00299.2010","volume":"301","author":"LA Mitchell","year":"2011","unstructured":"Mitchell LA, Overgaard CE, Ward C, Margulies SS, Koval M. Differential effects of claudin-3 and claudin-4 on alveolar epithelial barrier function. Am J Physiol Lung Cell Mol Physiol. 2011;301:L40\u20139.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1226_CR31","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1136\/bmj.320.7246.1368","volume":"320","author":"S Shrewsbury","year":"2000","unstructured":"Shrewsbury S, Pyke S, Britton M. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). Bmj. 2000;320:1368\u201373.","journal-title":"Bmj"},{"key":"1226_CR32","doi-asserted-by":"publisher","first-page":"S261","DOI":"10.1067\/mai.2002.129705","volume":"110","author":"IM Adcock","year":"2002","unstructured":"Adcock IM, Maneechotesuwan K, Usmani O. Molecular interactions between glucocorticoids and long-acting beta2-agonists. J Allergy Clin Immunol. 2002;110:S261\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"1226_CR33","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1164\/rccm.200408-1041OC","volume":"172","author":"OS Usmani","year":"2005","unstructured":"Usmani OS, Ito K, Maneechotesuwan K, Ito M, Johnson M, Barnes PJ, Adcock IM. Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. Am J Respir Crit Care Med. 2005;172:704\u201312.","journal-title":"Am J Respir Crit Care Med"},{"key":"1226_CR34","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(02)11319-5","volume":"360","author":"M Roth","year":"2002","unstructured":"Roth M, Johnson PR, Rudiger JJ, King GG, Ge Q, Burgess JK, Anderson G, Tamm M, Black JL. Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet. 2002;360:1293\u20139.","journal-title":"Lancet"},{"key":"1226_CR35","first-page":"L41","volume":"268","author":"JC Mak","year":"1995","unstructured":"Mak JC, Nishikawa M, Barnes PJ. Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Phys. 1995;268:L41\u20136.","journal-title":"Am J Phys"},{"key":"1226_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1189\/jlb.0609382","volume":"87","author":"M Doss","year":"2010","unstructured":"Doss M, White MR, Tecle T, Hartshorn KL. Human defensins and LL-37 in mucosal immunity. J Leukoc Biol. 2010;87:79\u201392.","journal-title":"J Leukoc Biol"},{"key":"1226_CR37","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.4049\/jimmunol.171.12.6690","volume":"171","author":"GS Tjabringa","year":"2003","unstructured":"Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sorensen OE, Borregaard N, Rabe KF, Hiemstra PS. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol. 2003;171:6690\u20136.","journal-title":"J Immunol"},{"key":"1226_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0168-3659(02)00356-5","volume":"87","author":"BI Florea","year":"2003","unstructured":"Florea BI, Cassara ML, Junginger HE, Borchard G. Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J Control Release. 2003;87:131\u20138.","journal-title":"J Control Release"},{"key":"1226_CR39","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1007\/s11095-006-0255-0","volume":"23","author":"CI Grainger","year":"2006","unstructured":"Grainger CI, Greenwell LL, Lockley DJ, Martin GP, Forbes B. Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier. Pharm Res. 2006;23:1482\u201390.","journal-title":"Pharm Res"},{"key":"1226_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1165\/ajrcmb.10.3.8117445","volume":"10","author":"PM de Jong","year":"1994","unstructured":"de Jong PM, van Sterkenburg MA, Hesseling SC, Kempenaar JA, Mulder AA, Mommaas AM, Dijkman JH, Ponec M. Ciliogenesis in human bronchial epithelial cells cultured at the air-liquid interface. Am J Respir Cell Mol Biol. 1994;10:271\u20137.","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1226-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-019-1226-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1226-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T00:32:36Z","timestamp":1604795556000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-019-1226-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,9]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1226"],"URL":"https:\/\/doi.org\/10.1186\/s12931-019-1226-4","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,9]]},"assertion":[{"value":"3 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KK received a research grant from MSD Life Science Foundation, Public Interest Incorporated Foundation that was unrelated to the submitted work. KM received honorarium for educational lectures from AstraZeneca. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}